Tech Company Financing Transactions
NewLeaf Symbiotics Funding Round
On 1/12/2013, NewLeaf Symbiotics raised $7 million in funding from Open Prairie Ventures, Pangaea Ventures and RockPort Capital.
Transaction Overview
Company Name
Announced On
1/12/2013
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Undisclosed
Investors
Open Prairie Ventures (Jason Wrone)
Pangaea Ventures (Keith Gillard)
RockPort Capital (Kevin Kopczynski)
Proceeds Purpose
With this round of financing completed, NewLeaf is well positioned to further its field trials across a number of key market segments, advance product formulation efforts, and to expand its growing portfolio of intellectual property.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1005 North Warson Rd.
St. Louis, MO 63132
USA
St. Louis, MO 63132
USA
Phone
Website
Email Address
Overview
NewLeaf Symbiotics is a science-based company doing cutting-edge research and product development, using a naturally occurring family of beneficial plant bacteria.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stephen Kahn
Chief Scientific Officer
Desmond Jimenez
Chief Technical Officer
Janne Kerovuo
VP - Bus. Development
Matthew Helms
VP - General Counsel
Molly Edwards
VP - Manufacturing
Aaron Kelley
VP - R & D
Natalie Breakfield
Browse more venture capital transactions:
Prev: 1/11/2013: SR Labs venture capital transaction
Next: 1/14/2013: AutoGenomics venture capital transaction
Share this article
News on VC Transactions
We do our best to document tech company VC transactions. All VC database entries reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs